Institutional investors purchased a net $1.7 million shares of ZIOP during the quarter ended June 2014 and now own 30.10% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.9 Million shares of ZIOPHARM Oncology Inc
THE VANGUARD GROUP, INC. Bought 317.0 Thousand shares of ZIOPHARM Oncology Inc
GROUP ONE TRADING LP Bought 223.0 Thousand shares of ZIOPHARM Oncology Inc